Shapiro David

CIK 00015595704 companiesCARLSBAD, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001559570

Recent Transactions

50 trades

Award
Design Therapeutics, Inc.$DSGN
Stock option (right to buy)
2026-03-31+7,500→ 7,500 total
Award
Design Therapeutics, Inc.$DSGN
Stock option (right to buy)
2026-03-31+60,000→ 60,000 total
Award
Damora Therapeutics, Inc.$DMRA
Stock Option (right to buy)
2025-06-18+720→ 720 total
Award
Damora Therapeutics, Inc.$DMRA
Stock Option (right to buy)
2024-06-20+18,000→ 18,000 total
Award
Damora Therapeutics, Inc.$DMRA
Stock Option (right to buy)
2023-06-14+18,000→ 18,000 total
Award
Damora Therapeutics, Inc.$DMRA
Stock Option (right to buy)
2022-06-14+18,000→ 18,000 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2019-09-05+52,000→ 52,000 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-05-01$31.90/sh+2,000→ 41,499 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-05-01−2,000→ 9,031 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-05-01$86.28/sh−2,000→ 39,499 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-04-15−2,000→ 11,031 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-04-15$95.00/sh−2,000→ 39,499 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-04-15$31.90/sh+2,000→ 41,499 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-04-03$115.01/sh−562→ 39,499 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-04-01$111.50/sh−482→ 40,061 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-03-01$103.16/sh−2,000→ 40,543 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-03-01$31.90/sh+2,000→ 42,543 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-03-01−2,000→ 13,031 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-02-15−2,000→ 15,031 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-02-15$31.90/sh+2,000→ 42,543 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-02-15$111.51/sh−2,000→ 40,543 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-01-16+5,300→ 5,300 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-01-16+3,300→ 40,543 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-01-04$97.48/sh−474→ 37,243 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-01-03$97.45/sh−699→ 37,717 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-01-02$31.90/sh+2,000→ 40,416 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-01-02$98.28/sh−2,000→ 38,416 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-01-02−2,000→ 17,031 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-01-01$100.79/sh−736→ 38,416 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-12-17$31.90/sh+2,000→ 41,152 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2018-12-17−2,000→ 19,031 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-12-17$106.62/sh−2,000→ 39,152 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2018-12-04+46,500→ 46,500 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2018-12-04+30,000→ 30,000 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-11-01$96.32/sh−2,000→ 39,152 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-11-01$21.50/sh+2,000→ 41,152 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2018-11-01−2,000→ 361 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-10-15$102.95/sh−3,425→ 39,152 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-10-15$21.50/sh+3,425→ 42,577 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2018-10-15−3,425→ 2,361 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-10-05$110.65/sh−759→ 39,152 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-10-01$126.46/sh−426→ 39,911 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-09-05$111.43/sh−4,917→ 42,196 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-07-01$83.91/sh−416→ 39,911 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-04-01$61.52/sh−423→ 39,911 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-02-05+2,900→ 47,113 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2018-02-05+4,400→ 4,400 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-01-01$58.42/sh−1,020→ 39,911 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2017-10-02$58.90/sh−349→ 44,213 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2017-09-01−1,250→ 21,031 total

Companies

Recent Filings

Address

C/O DESIGN THERAPEUTICS, INC. 6005 HIDDEN VALLEY ROAD, SUITE 110

CARLSBAD, CA, 92011

View on SEC.gov